Insider Transactions in Q2 2017 at Syneos Health, Inc. (SYNH)
Insider Transaction List (Q2 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,467
-11.28%
|
$549,086
$58.36 P/Share
|
|
Jun 30
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+10.14%
|
$151,472
$16.06 P/Share
|
|
Jun 30
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
5,917
-11.29%
|
$343,186
$58.28 P/Share
|
|
Jun 30
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
5,917
+10.14%
|
$94,672
$16.06 P/Share
|
|
Jun 30
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
867
-1.79%
|
$50,286
$58.5 P/Share
|
|
Jun 30
2017
|
Michael Gibertini |
SELL
Payment of exercise price or tax liability
|
Direct |
576
-1.0%
|
$33,408
$58.5 P/Share
|
|
Jun 30
2017
|
Gregory S Rush Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
967
-1.74%
|
$56,086
$58.5 P/Share
|
|
May 23
2017
|
David F Burgstahler Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+6.5%
|
-
|
|
May 23
2017
|
Robert W Breckon Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+30.78%
|
-
|
|
May 23
2017
|
Linda S Harty Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+45.64%
|
-
|
|
May 23
2017
|
Richard N Kender Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+27.37%
|
-
|
|
May 23
2017
|
William E Klitgaard Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+45.64%
|
-
|
|
May 23
2017
|
Kenneth F Meyers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+40.75%
|
-
|
|
May 23
2017
|
Matthew E. Monaghan Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+40.75%
|
-
|
|
May 23
2017
|
David Y Norton Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+27.82%
|
-
|
|
May 23
2017
|
Eric Paques Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,693
+45.42%
|
-
|
|
May 01
2017
|
Alistair Macdonald Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,467
-11.28%
|
$426,015
$45.0 P/Share
|
|
May 01
2017
|
Alistair Macdonald Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,467
+10.14%
|
$151,472
$16.06 P/Share
|
|
Apr 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
SELL
Open market or private sale
|
Direct |
4,733
-8.92%
|
$212,985
$45.7 P/Share
|
|
Apr 03
2017
|
Christopher L Gaenzle CAO, GC & Sec |
BUY
Exercise of conversion of derivative security
|
Direct |
4,733
+8.19%
|
$47,330
$10.57 P/Share
|